Imbalanced cyclic AMP-cyclic GMP levels in psoriasis.
D000818:Animals; D003994:Bucladesine / Q000494:pharmacology; D002454:Cell Differentiation / Q000187:drug effects; D002455:Cell Division / Q000187:drug effects; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism* / Q000494:pharmacology / Q000502:physiology; D006152:Cyclic GMP / Q000378:metabolism* / Q000494:pharmacology / Q000502:physiology; D004247:DNA / Q000096:biosynthesis; D006003:Glycogen / Q000378:metabolism; D006801:Humans; D051379:Mice; D010208:Papaverine / Q000494:pharmacology; D011565:Psoriasis / Q000378:metabolism* / Q000473:pathology; D012867:Skin / Q000187:drug effects / Q000378:metabolism* / Q000473:pathology; D013806:Theophylline / Q000494:pharmacology; D014970:Xanthines / Q000494:pharmacology
D014970:Xanthines; D003994:Bucladesine; D006003:Glycogen; D004247:DNA; D013806:Theophylline; D010208:Papaverine; D000242:Cyclic AMP; D006152:Cyclic GMP